HR-Positive and Triple-Negative Metastatic Breast Cancer | Professor Peter Schmid, FRCP, MD, PhD

Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer | Faculty Presentation 2: Other Targets for ADC Therapy in mBC — Professor Peter Schmid, FRCP, MD, PhD

CME information and select publications